Pacira BioSciences Reports Third Quarter 2019 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Pacira BioSciences Reports Third Quarter 2019 Financial Results and Business Update

Pacira Pharma (PCRX) Tops Q3 EPS by 15c

November 7, 2019 8:12 AM EST

Pacira Pharma (NASDAQ: PCRX) reported Q3 EPS of $0.48, $0.15 better than the analyst estimate of $0.33. Revenue for the quarter came in at $104.7 million versus the consensus estimate of $105.28 million.

2019 Financial Guidance:

Pacira reiterated its full year 2019 financial guidance as... More